Class Action Lawsuits Against Ardent Health and Varonis Systems Reminder
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy VRNS?
Source: Globenewswire
- Ardent Health Lawsuit: A class action lawsuit against Ardent Health alleges that the company failed to disclose the collectability of accounts receivable from July 18, 2024, to November 12, 2025, resulting in significant investor losses, with a deadline of March 9, 2026, for investors to apply as lead plaintiffs to protect their rights.
- Varonis Systems Lawsuit: A class action lawsuit against Varonis Systems claims that the company did not disclose its ability to convert its customer base and its ARR growth potential between February 4, 2025, and October 28, 2025, with a similar deadline of March 9, 2026, for investors to seek lead plaintiff status.
- Law Firm Background: Holzer & Holzer, LLC is an ISS top-rated securities litigation law firm from 2021 to 2025, dedicated to vigorously representing shareholders and investors, having recovered hundreds of millions of dollars for shareholders affected by fraud and corporate misconduct.
- Contact Information: Investors seeking more information can contact attorney Corey D. Holzer via email or phone, or visit Holzer & Holzer's website for legal support.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VRNS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VRNS
Wall Street analysts forecast VRNS stock price to rise
18 Analyst Rating
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 22.720
Low
37.00
Averages
52.18
High
80.00
Current: 22.720
Low
37.00
Averages
52.18
High
80.00
About VRNS
Varonis Systems, Inc. is a data security company. The Company’s cloud-native data security platform discovers and classifies critical data, removes exposures, and detects advanced threats with artificial intelligence (AI)-powered automation. Varonis software enables enterprises of all sizes and industries to protect data stored in the cloud and on-premises, including sensitive files, emails and databases; confidential personal data belonging to customers, patients and employees; financial records; source code, strategic and product plans; and other intellectual property. Its SaaS product portfolio includes two product lines: its flagship Varonis Data Security Platform, which protects Microsoft 365, Windows file shares, Active Directory, Edge devices (VPN, DNS, proxy), UNIX/Linux and hybrid NAS storage, and DatAdvantage Cloud, which protects IaaS environments and SaaS applications, such as Salesforce, AWS, Azure, Google Cloud, Google Workspace, Databricks, ServiceNow, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Varonis Faces Securities Class Action Investigation Over Revenue Decline
- Investigation Launched: Hagens Berman law firm is investigating whether Varonis Systems, Inc. executives concealed significant renewal softness in its Federal and legacy on-premises businesses while promoting a transition to a SaaS platform, potentially leading to investor losses.
- Revenue Decline: On October 28, 2025, Varonis disclosed that its shift to a SaaS model was hampered by an inability to convert existing customers at the expected pace, resulting in a 63.9% year-over-year decline in term license revenue and a reduced annual recurring revenue (ARR) outlook.
- Stock Price Crash: This disclosure triggered a 48% single-day stock crash, wiping out approximately $3.8 billion in market value, indicating strong investor concerns about the company's future prospects, which could affect its financing capabilities and market trust.
- Investor Action Call: Hagens Berman urges investors who purchased Varonis shares between February 4, 2025, and October 28, 2025, and suffered substantial losses to submit their loss information promptly to participate in the upcoming litigation.
See More
Varonis Faces Class Action Lawsuit Impacting Stock Price
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Varonis Systems, alleging securities fraud and other unlawful business practices, with investors advised to apply as Lead Plaintiff by March 9, 2026.
- Disappointing Earnings: Varonis reported third-quarter 2025 results that missed consensus estimates, notably a 63.9% year-over-year decline in term license subscription revenues, indicating significant challenges in its business model.
- Guidance Reduction: Management announced a reduction in full-year ARR guidance primarily due to underperformance in its on-premises subscription business, citing sales process issues as a factor contributing to lower renewal rates, which further hampers overall growth.
- Stock Price Plunge: Following the earnings report, Varonis's stock price plummeted by 48.67%, dropping $30.66 to close at $32.34, reflecting strong market concerns regarding the company's future outlook.
See More
Class Action Lawsuits Against Ardent Health and Varonis Systems Reminder
- Ardent Health Lawsuit: A class action lawsuit against Ardent Health alleges that the company failed to disclose the collectability of accounts receivable from July 18, 2024, to November 12, 2025, resulting in significant investor losses, with a deadline of March 9, 2026, for investors to apply as lead plaintiffs to protect their rights.
- Varonis Systems Lawsuit: A class action lawsuit against Varonis Systems claims that the company did not disclose its ability to convert its customer base and its ARR growth potential between February 4, 2025, and October 28, 2025, with a similar deadline of March 9, 2026, for investors to seek lead plaintiff status.
- Law Firm Background: Holzer & Holzer, LLC is an ISS top-rated securities litigation law firm from 2021 to 2025, dedicated to vigorously representing shareholders and investors, having recovered hundreds of millions of dollars for shareholders affected by fraud and corporate misconduct.
- Contact Information: Investors seeking more information can contact attorney Corey D. Holzer via email or phone, or visit Holzer & Holzer's website for legal support.
See More
Faruqi & Faruqi Investigates Varonis Securities Litigation
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Varonis Systems, Inc., particularly for investors who purchased securities between February 4, 2025, and October 28, 2025, aiming to provide legal support for affected investors.
- Financial Performance Miss: Varonis reported significant misses in its third-quarter financial results on October 28, 2025, with annual recurring revenue (ARR) falling short of expectations and a downward revision of its full-year guidance, resulting in a nearly 48.67% drop in stock price in a single day.
- False Statement Allegations: The lawsuit alleges that Varonis and its executives violated federal securities laws by making false and misleading statements and failing to disclose their true ability to convert existing customers to the SaaS solution, leading investors to purchase securities at artificially inflated prices.
- Investor Rights Protection: Faruq & Faruqi reminds investors that March 9 is the deadline to seek the role of lead plaintiff in the federal securities class action, encouraging anyone with information to contact the firm to support affected investors.
See More
Varonis Systems Faces Securities Fraud Class Action Reminder
- Lawsuit Background: Varonis Systems, Inc. (NASDAQ: VRNS) is facing a securities fraud class action lawsuit alleging that its executives made false statements regarding the company's ability to convert its customer base between February 4 and October 28, 2025, resulting in investor losses.
- Investor Action: Investors must file papers by March 9, 2026, to serve as lead plaintiffs in the class action, although they can still share in any recovery without taking on this role, highlighting the legal process's role in protecting investor rights.
- Law Firm's Role: Bernstein Liebhard LLP, representing the plaintiffs, has recovered over $3.5 billion for clients since 1993, demonstrating its extensive experience and success in securities litigation.
- Potential Impact: The lawsuit's allegations could affect Varonis's annual recurring revenue growth potential, potentially leading to stock price volatility, prompting investors to closely monitor developments to assess investment risks.
See More
Varonis Systems Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Varonis Systems (NASDAQ:VRNS) common stock between February 4, 2025, and October 28, 2025, that they must apply to be lead plaintiff by March 9, 2026, or risk losing the opportunity to represent other investors in the class action.
- Lawsuit Background: The lawsuit alleges that Varonis failed to maintain annual recurring revenue (ARR) projections and could not effectively persuade existing customers to transition to the software-as-a-service (SaaS) model, resulting in significantly reduced ARR growth potential in the near term, which misled investors and caused them damages.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, recovering over $438 million for investors in 2019 alone, showcasing its strong capabilities and successful track record in this field.
- Investor Guidance: Investors are advised to carefully select counsel with proven success in leadership roles, avoiding firms that merely act as intermediaries, to ensure they receive the best legal support and potential compensation in the class action.
See More
Varonis Faces Securities Class Action Investigation Over Revenue Decline
- Investigation Launched: Hagens Berman law firm is investigating whether Varonis Systems, Inc. executives concealed significant renewal softness in its Federal and legacy on-premises businesses while promoting a transition to a SaaS platform, potentially leading to investor losses.
- Revenue Decline: On October 28, 2025, Varonis disclosed that its shift to a SaaS model was hampered by an inability to convert existing customers at the expected pace, resulting in a 63.9% year-over-year decline in term license revenue and a reduced annual recurring revenue (ARR) outlook.
- Stock Price Crash: This disclosure triggered a 48% single-day stock crash, wiping out approximately $3.8 billion in market value, indicating strong investor concerns about the company's future prospects, which could affect its financing capabilities and market trust.
- Investor Action Call: Hagens Berman urges investors who purchased Varonis shares between February 4, 2025, and October 28, 2025, and suffered substantial losses to submit their loss information promptly to participate in the upcoming litigation.
See More
Varonis Faces Class Action Lawsuit Impacting Stock Price
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Varonis Systems, alleging securities fraud and other unlawful business practices, with investors advised to apply as Lead Plaintiff by March 9, 2026.
- Disappointing Earnings: Varonis reported third-quarter 2025 results that missed consensus estimates, notably a 63.9% year-over-year decline in term license subscription revenues, indicating significant challenges in its business model.
- Guidance Reduction: Management announced a reduction in full-year ARR guidance primarily due to underperformance in its on-premises subscription business, citing sales process issues as a factor contributing to lower renewal rates, which further hampers overall growth.
- Stock Price Plunge: Following the earnings report, Varonis's stock price plummeted by 48.67%, dropping $30.66 to close at $32.34, reflecting strong market concerns regarding the company's future outlook.
See More
Class Action Lawsuits Against Ardent Health and Varonis Systems Reminder
- Ardent Health Lawsuit: A class action lawsuit against Ardent Health alleges that the company failed to disclose the collectability of accounts receivable from July 18, 2024, to November 12, 2025, resulting in significant investor losses, with a deadline of March 9, 2026, for investors to apply as lead plaintiffs to protect their rights.
- Varonis Systems Lawsuit: A class action lawsuit against Varonis Systems claims that the company did not disclose its ability to convert its customer base and its ARR growth potential between February 4, 2025, and October 28, 2025, with a similar deadline of March 9, 2026, for investors to seek lead plaintiff status.
- Law Firm Background: Holzer & Holzer, LLC is an ISS top-rated securities litigation law firm from 2021 to 2025, dedicated to vigorously representing shareholders and investors, having recovered hundreds of millions of dollars for shareholders affected by fraud and corporate misconduct.
- Contact Information: Investors seeking more information can contact attorney Corey D. Holzer via email or phone, or visit Holzer & Holzer's website for legal support.
See More
Faruqi & Faruqi Investigates Varonis Securities Litigation
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Varonis Systems, Inc., particularly for investors who purchased securities between February 4, 2025, and October 28, 2025, aiming to provide legal support for affected investors.
- Financial Performance Miss: Varonis reported significant misses in its third-quarter financial results on October 28, 2025, with annual recurring revenue (ARR) falling short of expectations and a downward revision of its full-year guidance, resulting in a nearly 48.67% drop in stock price in a single day.
- False Statement Allegations: The lawsuit alleges that Varonis and its executives violated federal securities laws by making false and misleading statements and failing to disclose their true ability to convert existing customers to the SaaS solution, leading investors to purchase securities at artificially inflated prices.
- Investor Rights Protection: Faruq & Faruqi reminds investors that March 9 is the deadline to seek the role of lead plaintiff in the federal securities class action, encouraging anyone with information to contact the firm to support affected investors.
See More
Varonis Systems Faces Securities Fraud Class Action Reminder
- Lawsuit Background: Varonis Systems, Inc. (NASDAQ: VRNS) is facing a securities fraud class action lawsuit alleging that its executives made false statements regarding the company's ability to convert its customer base between February 4 and October 28, 2025, resulting in investor losses.
- Investor Action: Investors must file papers by March 9, 2026, to serve as lead plaintiffs in the class action, although they can still share in any recovery without taking on this role, highlighting the legal process's role in protecting investor rights.
- Law Firm's Role: Bernstein Liebhard LLP, representing the plaintiffs, has recovered over $3.5 billion for clients since 1993, demonstrating its extensive experience and success in securities litigation.
- Potential Impact: The lawsuit's allegations could affect Varonis's annual recurring revenue growth potential, potentially leading to stock price volatility, prompting investors to closely monitor developments to assess investment risks.
See More
Varonis Systems Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Varonis Systems (NASDAQ:VRNS) common stock between February 4, 2025, and October 28, 2025, that they must apply to be lead plaintiff by March 9, 2026, or risk losing the opportunity to represent other investors in the class action.
- Lawsuit Background: The lawsuit alleges that Varonis failed to maintain annual recurring revenue (ARR) projections and could not effectively persuade existing customers to transition to the software-as-a-service (SaaS) model, resulting in significantly reduced ARR growth potential in the near term, which misled investors and caused them damages.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, recovering over $438 million for investors in 2019 alone, showcasing its strong capabilities and successful track record in this field.
- Investor Guidance: Investors are advised to carefully select counsel with proven success in leadership roles, avoiding firms that merely act as intermediaries, to ensure they receive the best legal support and potential compensation in the class action.
See More
